Elmiron (generic name pentosan) is a prescription medication used in the treatment of a painful bladder syndrome called interstitial cystitis. More than one million people in the United States suffer interstitial cystitis, and Elmiron is the only FDA approved medication to treat the condition. Hundreds of thousands of these patients may have been treated with Elmiron and are potentially at risk of severe eye damage and even vision loss.
Elmiron has been linked to a severe eye condition called Maculopathy. Contact us now, you may qualify for financial compensation.
Recent medical research has linked Elmiron to an eye disease known as maculopathy – which means that your retina is being damaged. This eye damage worsens with time, often before symptoms begin which include:
The side effects of Elmiron are still being studied by the science and medical communities. Currently, data shows that of participants studied, those who were on the medication for an extended period had a significantly higher risk of presenting with atypical Maculopathy. Unfortunately, researchers have not been able to determine if stopping treatment with the medication will alter the course of the eye disease.
We are currently investigating cancer claims on behalf of patients and consumers who used Elmiron and developed the eye disease known as maculopathy. But the countdown for how long you have to file a claim has already begun. Don’t delay, call now.